Buscar

25/12/2023 A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Macia, M, Díaz-Encarnación, M, Solans-Laqué, R, Mallol, EP, Castells, AG, Escribano, C, de Arellano, AR. A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain. Expert Review of Pharmacoeconomics & Outcomes Research. 2023; 24(2)DOI:10.1080/14737167.2023.2297790. PMID:38126738. IF:1.800(Q3/6D).
09/11/2023 Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!
Torra, R, Kronbichler, A, Bajema, IM. Replacing a kidney biopsy by exome sequencing in undetermined kidney diseases-not yet ready for prime time!. Clinical Kidney Journal. 2023; 17(1)DOI:10.1093/ckj/sfad250. PMID:38186890. IF:3.900(Q1/2D).
01/10/2023 On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).
29/09/2023 Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia, SC, Downie, ML, Kim, JS, Boyer, O, Walsh, SB, Nijenhuis, T, Papizh, S, Yadav, P, Reynolds, B, Decramer, S, Besouw, M, Carrascosa, MP, La Scola, C, Trepiccione, F, Ariceta, G, Hummel, A, Dossier, C, Sayer, JA, Konrad, M, Keijzer-Veen, MG, Awan, A, Basu, B, Chauveau, D, Madariaga, L, Koster-Kamphuis, L, Furlano, M, Zacchia, M, Marzuillo, P, Tse, Y, Dursun, I, Pinarbasi, AS, Tramma, D, Hoorn, EJ, Gokce, I, Nicholls, K, Eid, LA, Sartz, L, Riordan, M, Hooman, N, Printza, N, Bonny, O, Sancho, PA, Schild, R, Sinha, R, Guarino, S, Jimenez, VM, Peña, LR, Belge, H, Devuyst, O, Wlodkowski, T, Emma, F, Levtchenko, E, Knoers, NVAM, Bichet, DG, Schaefer, F, Kleta, R, European NDI Consortium, Bockenhauer, D. Treatment and long-term outcome in primary nephrogenic diabetes insipidus. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(10)DOI:10.1093/ndt/gfaa243. PMID:33367818. IF:4.800(Q1/2D).